.png){kind=icon}
.png){kind=icon}
Return
Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [177Lu] Lu-PSMA-617 therapy: a case report
.png){kind=icon}
OA
AI
DOI：10.3389/fonc.2024.1442293.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Radioligand therapies such as [Lu-177] Lu-PSMA-617 have gained significant momentum in cancer treatment after clinical trials and multicenter studies demonstrated their safety and efficacy. As these innovative treatments become more widespread, rare and unique clinical manifestations are expected to be observed. In this report, we describe a case with metastatic castration-resistant prostate cancer (mCRPC) and peripancreatic lymph node metastases who developed acute pancreatitis following [Lu-177] Lu-PSMA-617 therapy.
Keywords:
prostate cancer
Lu-PSMA
theranosctics
acute pancreatitis
inflammation
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.